Feasibility of integrated CT-liver perfusion in routine FDG-PET/CT
暂无分享,去创建一个
Valerie Treyer | Patrick Veit-Haibach | Klaus Strobel | Thomas F. Hany | Lars Husmann | V. Treyer | L. Husmann | P. Veit-Haibach | T. Hany | N. Schaefer | K. Strobel | Alois Tschopp | Niklaus G. Schaefer | A. Tschopp | Jan D. Soyka | J. Soyka
[1] S. Meijer,et al. Total-liver-volume perfusion CT using 3-D image fusion to improve detection and characterization of liver metastases , 2008, European Radiology.
[2] Fabian Kiessling,et al. Perfusion CT in patients with advanced bronchial carcinomas: a novel chance for characterization and treatment monitoring? , 2004, European Radiology.
[3] Randall C. Thompson,et al. Radiation Dose to Patients From Cardiac Diagnostic Imaging , 2007, Circulation.
[4] 김주희,et al. Optimal Delay Time for the Hepatic Parenchymal Enhancement at the Multidetector CT Examination , 2006 .
[5] Heiko Schöder,et al. PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[6] A. Elster. Impact of Positron Emission Tomography/Computed Tomography and Positron Emission Tomography (PET) Alone on Expected Management of Patients With Cancer: Initial Results From the National Oncologic PET Registry , 2009 .
[7] C. Yi,et al. Solitary pulmonary nodules: dynamic enhanced multi-detector row CT study and comparison with vascular endothelial growth factor and microvessel density. , 2004, Radiology.
[8] Martijn R. Meijerink,et al. The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients , 2007, European Radiology.
[9] Lee M Ellis,et al. Functional CT for quantifying tumor perfusion in antiangiogenic therapy in a rat model. , 2005, Radiology.
[10] K. Miles,et al. Perfusion CT for the assessment of tumour vascularity: which protocol? , 2003, The British journal of radiology.
[11] Andreas Friedl,et al. Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] S Nahum Goldberg,et al. Perfusion MDCT enables early detection of therapeutic response to antiangiogenic therapy. , 2008, AJR. American journal of roentgenology.
[13] Steve Halligan,et al. Quantitative assessment of colorectal cancer tumor vascular parameters by using perfusion CT: influence of tumor region of interest. , 2008, Radiology.
[14] Peter J. Ell,et al. Metabolic–flow relationships in primary breast cancer: feasibility of combined PET/dynamic contrast-enhanced CT , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[15] Y. Erdi,et al. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[16] H. Steinert,et al. Therapy response evaluation in malignant pleural mesothelioma with integrated PET-CT imaging. , 2005, Lung cancer.
[17] Yu Wang,et al. Dynamic CT Evaluation of Tumor Vascularity in Renal Cell Carcinoma. , 2006, AJR. American journal of roentgenology.
[18] T. Beyer,et al. Diagnostic accuracy of colorectal cancer staging with whole-body PET/CT colonography. , 2006, JAMA.
[19] N. Holalkere,et al. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue--initial experience. , 2007, Radiology.
[20] Jr. P.G. Lang. High-Risk Melanoma: Accuracy of FDG PET/CT with Added CT Morphologic Information for Detection of Metastases , 2009 .
[21] Z. Rumboldt,et al. Whole-Tumor Perfusion CT Parameters and Glucose Metabolism Measurements in Head and Neck Squamous Cell Carcinomas: A Pilot Study Using Combined Positron-Emission Tomography/CT Imaging , 2008, American Journal of Neuroradiology.
[22] Ricky T. Tong,et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer , 2004, Nature Medicine.
[23] P. Valk,et al. Whole-body PET imaging with [18F]fluorodeoxyglucose in management of recurrent colorectal cancer. , 1999, Archives of surgery.
[24] Roslyn J. Francis,et al. Early Prediction of Response to Chemotherapy and Survival in Malignant Pleural Mesothelioma Using a Novel Semiautomated 3-Dimensional Volume-Based Analysis of Serial 18F-FDG PET Scans , 2007, Journal of Nuclear Medicine.
[25] W Van den Bogaert,et al. Tumoural perfusion as measured by dynamic computed tomography in head and neck carcinoma. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[26] Massimo Bellomi,et al. CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience. , 2007, Radiology.
[27] D. Sahani,et al. Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations. , 2005, Radiology.
[28] K. Miles,et al. Blood flow–metabolic relationships are dependent on tumour size in non-small cell lung cancer: a study using quantitative contrast-enhanced computer tomography and positron emission tomography , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[29] Larson,et al. Tumor Burden Assessment with Positron Emission Tomography with , 2000, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.